Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review.

Journal of Nanobiotechnology
Ying ZhangZhidong Liu

Abstract

Although nanomedicine have greatly developed and human life span has been extended, we have witnessed the soared incidence of central nervous system (CNS) diseases including neurodegenerative diseases (Alzheimer's disease, Parkinson's disease), ischemic stroke, and brain tumors, which have severely damaged the quality of life and greatly increased the economic and social burdens. Moreover, partial small molecule drugs and almost all large molecule drugs (such as recombinant protein, therapeutic antibody, and nucleic acid) cannot cross the blood-brain barrier. Therefore, it is especially important to develop a drug delivery system that can effectively deliver therapeutic drugs to the central nervous system for the treatment of central nervous system diseases. Cell penetrating peptides (CPPs) provide a potential strategy for the transport of macromolecules through the blood-brain barrier. This study analyzed and summarized the progress of CPPs in CNS diseases from three aspects: CPPs, the conjugates of CPPs and drug, and CPPs modified nanoparticles to provide scientific basis for the application of CPPs for CNS diseases.

References

Nov 4, 2000·Journal of Neurotrauma·A LewénP H Chan
Jan 10, 2001·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·P H Chan
Aug 8, 2002·Journal of Drug Targeting·Christophe RousselleJean-Michel Scherrmann
Dec 12, 2002·Proceedings of the National Academy of Sciences of the United States of America·Sadamitsu AsohShigeo Ohta
Mar 16, 2004·Lancet·Werner HackeUNKNOWN NINDS rt-PA Study Group Investigators
Nov 19, 2004·Nature·Sheila K SinghPeter B Dirks
Jul 19, 2005·Cancer Research·Jennifer A ChanKenneth S Kosik
Apr 23, 2009·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Thorsten R DoeppnerMathias Bähr
Nov 21, 2009·FEBS Letters·Nathan SchmidtGerard C L Wong
Jan 21, 2010·Nature Reviews. Neuroscience·Christian GiaumeNathalie Rouach
Apr 12, 2011·Journal of the American Chemical Society·Joshua T RobinsonHongjie Dai
Jan 10, 2012·Cold Spring Harbor Perspectives in Medicine·Alberto Serrano-PozoBradley T Hyman
Oct 20, 2012·Nanoscale·Morteza MahmoudiSeyyed Mohammad Amin Ghiasi
Jan 29, 2013·Bioconjugate Chemistry·Elo EristeÜlo Langel
Jan 29, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Gitanjali SharmaJagdish Singh
Jun 13, 2013·Biomaterials·Mingliang TangGuosheng Cheng
Aug 29, 2013·Molecular Therapy. Nucleic Acids·Kim A LennoxMark A Behlke
Oct 9, 2013·Proceedings of the National Academy of Sciences of the United States of America·Sohila ZadranR D Levine
Oct 15, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Huile GaoXinguo Jiang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Related Papers

International Journal of Environmental Research and Public Health
Keren GrinbergRachel Nissanholtz-Gannot
Current Pharmaceutical Biotechnology
Young Suk ChoiYoon Jeong Park
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
Yuan Tian, Shaobing Zhou
© 2021 Meta ULC. All rights reserved